This American Airlines Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Wedbush analyst David Nierengarten downgraded the rating for Ikena Oncology, Inc. IKNA from Outperform to Neutral, while slashing the price target from $8 to $2. Ikena Oncology shares closed at $1.33 on Tuesday. See how other analysts view this stock.
Wells Fargo analyst Finian O’Shea downgraded Goldman Sachs BDC, Inc. GSBD from Equal-Weight to Underweight and cut the price target from $15 to $14. Goldman Sachs BDC shares fell 0.1% to settle at $15.18 on Tuesday. See how other analysts view this stock.
Citigroup analyst Benjamin Gerlinger downgraded the rating for Bank OZK OZK from Buy to Sell, while cutting the price target from $57 to $37. Bank OZK shares fell 0.7% to settle at $46.19 on Tuesday. See how other analysts view this stock. See how other analysts view this stock.
Jefferies analyst Sheila Kahyaoglu downgraded American Airlines Group Inc. AAL from Buy to Hold and slashed the price target from $17 to $12. American Airlines shares fell 2.9% to close at $13.44 on Tuesday. See how other analysts view this stock.
Baird analyst David Manthey downgraded the rating for WESCO International, Inc. WCC from Outperform to Neutral, while lowering the price target from $200 to $195. WESCO shares fell 3% to settle at $185.52 on Tuesday. See how other analysts view this stock.